Source:http://linkedlifedata.com/resource/pubmed/id/16497092
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-3-26
|
pubmed:abstractText |
In this study, we describe changes of plasma levels of the hypothalamic neuropeptide orexin A in obese children during the reduction of body weight and its relationship to other biochemical and anthropometrical parameters. We measured orexin A fasting plasma levels by the RIA method in 58 obese children--33 girls and 25 boys; mean age 13.1+/-0.38 years (range 7-18.5) before and after 5 weeks of weight-reduction therapy. Leptin, IGF-1, and IGFBP-3 levels were measured in all the subjects and were compared to orexin A levels and anthropometrical data. Average weight in subjects before weight-reduction was 74.2+/-2.79 kg and after weight-loss 67.4+/-2.60 kg (p<0.0001). Orexin A levels before the therapy were 33.3+/-1.97 pg/ml and after the therapy 51.7+/-3.07 pg/ml (p<0.0001). Levels of orexin A were not significantly different between girls and boys (p=0.7842). We found negative correlation between orexin A and age (r = -0.5395; p<0.0001), body height (r = -0.4751; p=0.0002), body weight (r = -0.4030; p=0.0017) and BMI (r = -0.2607; p=0.0481). No correlation was found between orexin A and IGF-1, IGFBP-3 or leptin. Orexin A plasma levels increased during body weight loss, whereas the reverse was true for leptin levels. These findings support the hypothesis that orexin A may be involved in regulation of nutritional status in children.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Intracellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Leptin,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides,
http://linkedlifedata.com/resource/pubmed/chemical/orexins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0862-8408
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-96
|
pubmed:dateRevised |
2008-4-2
|
pubmed:meshHeading |
pubmed-meshheading:16497092-Adolescent,
pubmed-meshheading:16497092-Aging,
pubmed-meshheading:16497092-Body Height,
pubmed-meshheading:16497092-Body Mass Index,
pubmed-meshheading:16497092-Body Weight,
pubmed-meshheading:16497092-Child,
pubmed-meshheading:16497092-Female,
pubmed-meshheading:16497092-Humans,
pubmed-meshheading:16497092-Insulin-Like Growth Factor I,
pubmed-meshheading:16497092-Intracellular Signaling Peptides and Proteins,
pubmed-meshheading:16497092-Leptin,
pubmed-meshheading:16497092-Male,
pubmed-meshheading:16497092-Neuropeptides,
pubmed-meshheading:16497092-Nutritional Status,
pubmed-meshheading:16497092-Obesity,
pubmed-meshheading:16497092-Radioimmunoassay,
pubmed-meshheading:16497092-Weight Loss
|
pubmed:year |
2007
|
pubmed:articleTitle |
Dynamic changes of orexin A and leptin in obese children during body weight reduction.
|
pubmed:affiliation |
Department of Pediatrics, 2nd Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic. bronsky@email.cz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|